Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Metroprolol-succinate

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Metroprolol succinate Manufacturers in India Suppliers Metroprolol succinate Exporters Distributors Metroprolol succinate api active pharmaceuticals ingredients Metroprolol succinate manufacturers Side Effects bulk drugs raw material Metroprolol succinate companies Side Effects Importers Metroprolol succinate Metroprolol succinate Exporters Metroprolol succinate exporters FDA Metroprolol succinate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Metroprolol succinate manufacturing pharmaceutical drugs pharmaceutical intermediates Metroprolol succinate pharmaceutical chemicals pharmaceutical raw materials Metroprolol succinate active pharmaceutical ingredients Metroprolol succinate committee active pharmaceutical ingredients manufacturer Metroprolol succinate Active Pharmaceutical Ingredients manufacturer Metroprolol succinate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Metroprolol succinate, Metroprolol succinate manufacturer India, Metroprolol succinate product, Metroprolol succinate products, Api preparation, Certificate of Analysis API manufacturer product, Metroprolol succinate anti ulcer product, Certificate of Origin COA Metroprolol succinate COS Metroprolol succinate, pharmaceutical generic, pharmaceutical drug, medical, Metroprolol succinate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Metroprolol succinate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Metroprolol succinate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Metroprolol succinate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Metroprolol succinate ingredients, api, HIV Metroprolol succinate, tablets, capsules, syrup & protein Metroprolol succinate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Metroprolol succinate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Metroprolol succinate WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 

 long-term treatment of chest pain













 









 







 

 

HOME >> Pharmaceuticals API List 2 >> Metroprolol Succinate >> Side Effects

Metroprolol succinate, CAS NO 98418-47-4


SIDE EFFECTS
Metroprolol succinate CAS NO 98418-47-4

All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Blurred vision; constipation; diarrhea; dizziness; dry mouth/eyes; gas; headache; heartburn; lightheadedness; mild drowsiness; muscle aches; nausea; nightmares; stomach pain; trouble sleeping; unusual tiredness or weakness; vomiting.

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); blue or unusually cold hands or feet; chest pain; fainting; hallucinations; mood or mental changes (eg, confusion, depression); pounding in the chest; severe dizziness or lightheadedness; shortness of breath; slow or irregular heartbeat; swelling of the arms, hands, and feet; vision changes; wheezing; yellowing of the skin or eyes.

Hypertension and Angina

Most adverse effects have been mild and transient. The following adverse reactions have been reported for immediate release metoprolol tartrate.
Central Nervous System

Reversible mental depression progressing to catatonia; an acute reversible syndrome characterized by disorientation for time and place, short-term memory loss, emotional lability, slightly clouded sensorium, and decreased performance on neuropsychometrics.
Heart Failure

In the MERIT-HF study, serious adverse events and adverse events leading to discontinuation of study medication were systematically collected. In the MERIT-HF study comparing TOPROL-XL in daily doses up to 200 mg (mean dose 159 mg once-daily) (n=1990) to placebo (n=2001), 10.3% of TOPROL-XL patients discontinued for adverse events vs. 12.2% of placebo patients.

Information Associated with Product:
DRUG DESCRIPTION
DOSAGE
SIDE EFFECTS >>
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj Pharmaceuticals API Logo

Metoprolol Succinate

More Api at Taj Pharmaceuticals Ltd.

Lacidipine

Lamotrigine

Lansoprazole

Levetiracetam

Levo Cetirizine

Levofloxacin

Loratadine

Losartan Potassium

Metoprolol Succinate

Montelukast Sodium

Moxifloxacin HCl

Naproxen

Naratriptan

Norfloxacin

Nizatidine

Olmesartan

Omeprazole

Omeprazole Sodium

Oxaprozin

Paroxetine

Pantoprazole

Primidone

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited  products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.